详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

Experts consensus on epidemic prevention and control in radiotherapy centers during the COVID-19 outbreak: Experiences from Sichuan Province(Open Access)

114| 导出 | 链接全文 |

文献详情

资源类型：

WOS体系：

Pubmed体系：

收录情况： ◇ SCIE ◇ ESCI

作者：

机构： [1]Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China. [2]Sichuan Key Laboratory of Radiation Oncology, Chengdu, China. [3]Sichuan Anti-Cancer Association, Chengdu, China.

出处：

DOI：

关键词： Consensus COVID-19 Epidemic prevention and control Radiotherapy Radiotherapy center

摘要：

After the outbreak of COVID-19, medical institutions in China and even around the world are facing unprecedented challenges. In order to minimize the adverse impact of this unexpected epidemic on patients who need radiotherapy, the expert group of our radiotherapy center immediately formulated comprehensive emergency plans and prevention and control measures, partitioned the work area, launched online staff training, and optimized the radiotherapy process after the outbreak, which provided a strong guarantee for the safe and orderly operation of our radiotherapy center and kept the infection rate to an extremely low level. We hope our experience could provide reference and suggestions for other medical institutions. © 2020 The Authors

基金：

基金编号： 2017YFC0113100

语种：

被引次数：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2020]版：

无

最新[2023]版：

大类 | 3 区医学

小类 | 3 区肿瘤学 3 区核医学

JCR分区：

出版当年[2020]版：

无

最新[2023]版：

Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Q3 ONCOLOGY

影响因子： 2.7 最新[2023版] 3.3 最新五年平均 0 出版当年[2019版] 0 出版当年五年平均 0 出版前一年[2019版] 4.739 出版后一年[2021版]

第一作者：

第一作者机构： [1]Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China. [2]Sichuan Key Laboratory of Radiation Oncology, Chengdu, China. [3]Sichuan Anti-Cancer Association, Chengdu, China.

通讯作者：

通讯机构： [1]Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China. [2]Sichuan Key Laboratory of Radiation Oncology, Chengdu, China. [3]Sichuan Anti-Cancer Association, Chengdu, China. [*1]Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China. Sichuan Key Laboratory of Radiation Oncology. Sichuan Anti-Cancer Association, Chengdu, China.

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]四川省南充市16例新型冠状病毒感染患者就医行为分析 [2]头颈部肿瘤大分割放疗的研究进展及在新冠疫情中的临床价值 [3]Can We Use mTOR Inhibitors for COVID-19 Therapy? [4]Pre-COVID brain network topology prospectively predicts social anxiety alterations during the COVID-19 pandemic [5]The genetic associations of COVID-19 on genitourinary symptoms [6]新型冠状病毒肺炎疫情下临床试验病区管理防控策略 [7]从COVID-19疫情带来的新认知中寻找传染病应对之道 [8]Prevalence and risk factors for persistent symptoms after COVID-19: a systematic review and meta-analysis [9]环境卫生与监测：新常态下防控COVID-19的双轮效应思考 [10]Cuproptosis-associated lncRNA impact prognosis in patients with non-small cell lung cancer co-infected with COVID-19